Bluejay Diagnostics Inc (NASDAQ:BJDX) currently has a daily average trading volume of 1.16M but it saw 3613849 shares traded in last market. With a market cap of 3.09M USD, the company’s current market price of $2.07 came rising about 8.38 while comparing to the previous closing price of $1.91. In past 52 weeks, the stock remained buoying in the range of price level as high as $316.92 and as low as $1.46. In the recent trading on the day, stock has struck highest price mark of $1.87 while lowest mark touched by it was $2.08.
Taking a look at 20-day trading activity of Bluejay Diagnostics Inc (BJDX) gives us an average price of $2.4900, while its current price level is -99.35% below from 52-week high level whereas it is 41.78% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $3.3600 while that of 200 days or SMA-200 reads an average of $7.1200. A closer look into the stock’s movement over the week reveals that its volatility is standing at 16.54% during that period while stretching the period over a month that increases to 21.51%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 43.59 which implies that the stock is in neutral territory.
Over the week, BJDX’s stock price is moving 26.22% up while it is -42.82% when we observe its performance for the past one month. Year-to-date it is -57.49% down and over the past year, the stock is showing a downside performance of -99.07%.
The company is expected to be releasing its next quarterly report on 2024-Mar-27, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Bluejay Diagnostics Inc’s total number of outstanding shares is 0.55M with 0.25% of that held by the insiders while 2.48% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -358.14% and return on equity (ROE) at -178.98%. Stock’s beta reads 0.40. Stock has a price to book (P/B) ratio of 0.20. Its return on asset (ROA) is -133.92% on average.
